InvestorsHub on MSN
BioAffinity launches large-scale clinical study for lung cancer detection technology
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...
Ultracentrifugation (UC) remains a widely used method for isolating extracellular vesicles (EVs), but debates persist around yield, integrity, and optimal protocols. In this webinar, I will provide a ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Lysosomal storage diseases (LSDs) are genetic disorders caused by enzyme deficiencies ...
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of ...
Flow cytometry effectively detects CTCs in melanoma patients, offering a rapid, cost-effective alternative to molecular biology. CTCs are present across all melanoma stages, with a significant ...
Cytek Biosciences, Inc. has launched the Cytek® Muse® Micro, an enhanced version of its original Guava® Muse® cell analyzer, aimed at making advanced cell analysis more accessible and affordable. The ...
<li><a class="nav-link" href="#overview-of-fetal-hemoglobin-hbf-assay">Overview of Fetal Hemoglobin (HbF) Assay</a></li> <li><a class="nav-link" href="#flow-cytometry ...
Persistent immune activation is linked to elevated cardiovascular diseases in people with HIV on antiretroviral therapy. The fat attenuation index (FAI) is a measure of peri-coronary inflammation that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results